SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-20-015927
Filing Date
2020-06-26
Accepted
2020-06-26 14:53:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea123466-13dschuetz_compass.htm SC 13D 63303
2 FORM OF LOCK-UP AGREEMENT ea123466ex99-1_compass.htm EX-99.1 49914
  Complete submission text file 0001213900-20-015927.txt   114548
Mailing Address C/O RELYPSA, INC. 700 SAGINAW DR. REDWOOD CITY CA 94063
Business Address
Schuetz Thomas J. (Filed by) CIK: 0001591464 (see all company filings)

Type: SC 13D

Mailing Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142 617-500-8099
Compass Therapeutics, Inc. (Subject) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90878 | Film No.: 20993399
SIC: 6770 Blank Checks